4//SEC Filing
Siffert Joao MD 4
Accession 0001209191-22-062349
CIK 0001807120other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 5:00 PM ET
Size
6.8 KB
Accession
0001209191-22-062349
Insider Transaction Report
Form 4
Siffert Joao MD
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2022-12-20$8.38/sh+6,300$52,763→ 132,619 total - Purchase
Common Stock
2022-12-19$8.47/sh+1,150$9,741→ 126,319 total
Footnotes (2)
- [F1]Includes 1,250 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan ("ESPP") on November 15, 2021 and 1,220 shares acquired under the ESPP on May 13, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.32 to $8.44, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001534986
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 5:00 PM ET
- Size
- 6.8 KB